Table 4.
Sample Tested | IC50 of Cytotoxic Activity Against Tumor Cells | % of Viability in PBMCs | ||||
---|---|---|---|---|---|---|
MDA-MB-468 | MCF-7 | PBMCs | Concentration (µg/mL) | |||
12.5 | 3.125 | 0.78125 | ||||
Joo N | 14.30 ± 3.3 a | 10.10 ± 1.40 a | >50 a | 91.34 ± 7.72 a | 110.40 ± 9.51 a | 126.82 ± 10.70 a |
Joo B | 6.40 ± 1.1 b | 5.20 ± 2.00 b | 49 a | 60.40 ± 7.68 a | 106.30 ± 1.89 a | 118.59 ± 5.56 a |
CisP | 0.20 ± 0.0 c | 2.20 ± 0.40 c | 0.27 b | 16.08 ± 3.39 b | 30.08 ± 3.58 b | 37.96 ± 3.44 b |
Each value represents the mean ± standard deviation of three independents replicates. Different letters in the same column indicate significant differences (p < 0.05) within conditions according to two-way ANOVA multiple comparison range Test.